{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T00:02:22Z","timestamp":1790640142043,"version":"4.1.0"},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jocn-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Neuroscience"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.jocn.2026.112101","type":"journal-article","created":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T00:13:18Z","timestamp":1779927198000},"page":"112101","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Radiotherapy for newly diagnosed adult high grade gliomas in the Asia Pacific Region"],"prefix":"10.1016","volume":"151","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9865-0655","authenticated-orcid":false,"given":"A.","family":"Chua","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Brillante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Cupino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.Javier-","family":"Lizan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Legaspi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.C.","family":"Lapitan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jocn.2026.112101_b0005","doi-asserted-by":"crossref","unstructured":"Ostrom, Q. T., Cioffi, G., Gittleman, H., Patil, N., Waite, K., Kruchko, C., & Barnholtz-Sloan, J. S. (2019). CBTRUS Statistical Report: Primary brain and other central nervous system tumors diagnosed in the United States in 2012\u20132016. Neuro-Oncology, 21(Supplement_5), v1\u2013v100. https:\/\/doi.org\/10.1093\/neuonc\/noz150.","DOI":"10.1093\/neuonc\/noz150"},{"key":"10.1016\/j.jocn.2026.112101_b0010","doi-asserted-by":"crossref","unstructured":"Das, J.M. (2023). High-Grade Gliomas. In: Neuro-Oncology Explained Through Multiple Choice Questions. Springer, Cham. https:\/\/doi.org\/10.1007\/978-3-031-13253-7_15.","DOI":"10.1007\/978-3-031-13253-7"},{"issue":"35","key":"10.1016\/j.jocn.2026.112101_b0015","doi-asserted-by":"crossref","first-page":"4145","DOI":"10.1200\/JCO.2015.62.6606","article-title":"International Atomic Energy Agency randomized phase III study of radiation therapy in elderly and\/or frail patients with newly diagnosed glioblastoma multiforme","volume":"33","author":"Roa","year":"2015","journal-title":"J Clin Oncol"},{"issue":"9","key":"10.1016\/j.jocn.2026.112101_b0020","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/S1470-2045(12)70265-6","article-title":"Temozolomide versus standard 6-week radiotherapy versus hypofractionated radiotherapy in patients older than 60 years with glioblastoma: the Nordic randomised, phase 3 trial","volume":"13","author":"Malmstr\u00f6m","year":"2012","journal-title":"Lancet Oncol"},{"issue":"9","key":"10.1016\/j.jocn.2026.112101_b0025","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1200\/JCO.2004.06.082","article-title":"Abbreviated course of radiation therapy in older patients with glioblastoma multiforme: a prospective randomized clinical trial","volume":"22","author":"Roa","year":"2004","journal-title":"J Clin Oncol"},{"issue":"11","key":"10.1016\/j.jocn.2026.112101_b0030","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1056\/NEJMoa1611977","article-title":"Short-Course Radiation plus Temozolomide in elderly patients with Glioblastoma","volume":"376","author":"Perry","year":"2017","journal-title":"N Engl J Med"},{"issue":"15","key":"10.1016\/j.jocn.2026.112101_b0035","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1056\/NEJMoa065901","article-title":"Radiotherapy for glioblastoma in the elderly","volume":"356","author":"Keime-Guibert","year":"2007","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.jocn.2026.112101_b0040","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.ijrobp.2015.01.017","article-title":"Hypofractionated versus standard radiation therapy with or without temozolomide for older glioblastoma patients","volume":"92","author":"Arvold","year":"2015","journal-title":"International Journal of Radiation Oncology*Biology*Physics"},{"issue":"3","key":"10.1016\/j.jocn.2026.112101_b0045","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1007\/s11060-015-1745-x","article-title":"Hypofractionated stereotactic radiotherapy in combination with bevacizumab or fotemustine for patients with progressive malignant gliomas","volume":"122","author":"Minniti","year":"2015","journal-title":"J Neurooncol"},{"issue":"3","key":"10.1016\/j.jocn.2026.112101_b0050","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/s41571-020-00447-z","article-title":"EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood","volume":"18","author":"Weller","year":"2020","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.jocn.2026.112101_b0055","unstructured":"National Comprehensive Cancer Network. (2025). Central Nervous System Cancers (version 1.2025). Retrieved from https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/cns.pdf."},{"key":"10.1016\/j.jocn.2026.112101_b0060","unstructured":"Australian Cancer Network (2009). Clinical Practice Guidelines for the Management of Adult Gliomas: Astrocytomas and Oligodendrogliomas."},{"issue":"10","key":"10.1016\/j.jocn.2026.112101_b0065","doi-asserted-by":"crossref","first-page":"463","DOI":"10.47102\/annals-acadmedsg.V44N10p463","article-title":"Singapore Cancer Network (SCAN) guidelines for Systemic Therapy of High-Grade Glioma","volume":"44","author":"Singapore Cancer Network Neuro-oncology Workgroup","year":"2015","journal-title":"Ann Acad Med Singapore"},{"key":"10.1016\/j.jocn.2026.112101_b0070","volume":"15","author":"Ansari","year":"2017","journal-title":"A comprehensive approach in high-grade glioma management: position statement from the Neuro-Oncology Scientific Club (NOSC)"},{"issue":"2","key":"10.1016\/j.jocn.2026.112101_b0075","doi-asserted-by":"crossref","first-page":"83","DOI":"10.14791\/btrt.2022.0001","article-title":"The overview of Practical guidelines for Gliomas by KSNO, NCCN, and EANO","volume":"10","author":"Kim","year":"2022","journal-title":"Brain Tumor Research and Treatment"},{"issue":"7","key":"10.1016\/j.jocn.2026.112101_b0190","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1200\/GO.21.00029","article-title":"Global Radiotherapy: Current Status and Future Directions\u2014White Paper","volume":"7","author":"Abdel-Wahab","year":"2021","journal-title":"JCO Global Oncology"},{"issue":"2","key":"10.1016\/j.jocn.2026.112101_b0195","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.canlet.2016.01.024","article-title":"CGCG clinical practice guidelines for the management of adult diffuse gliomas","volume":"375","author":"Jiang","year":"2016","journal-title":"Cancer Lett"},{"issue":"1","key":"10.1016\/j.jocn.2026.112101_b0205","article-title":"CACA guidelines for holistic integrative management of glioma","volume":"1","author":"Fan","year":"2022","journal-title":"Holist Integr Oncol"},{"issue":"3","key":"10.1016\/j.jocn.2026.112101_b0210","doi-asserted-by":"crossref","first-page":"308","DOI":"10.3340\/jkns.2023.0046","article-title":"Korean Brain Tumor Society Consensus Review for the Practical Recommendations on Glioma Management in Korea","volume":"66","author":"Park","year":"2023","journal-title":"Journal of Korean Neurosurgical Society"},{"issue":"2","key":"10.1016\/j.jocn.2026.112101_b0080","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/ajco.12079","article-title":"Neuro\u2010oncology practices in Australia: a Cooperative Group for Neuro\u2010Oncology patterns of care study","volume":"10","author":"Chen","year":"2013","journal-title":"Asia Pac J Clin Oncol"},{"issue":"6","key":"10.1016\/j.jocn.2026.112101_b0085","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0129602","article-title":"International differences in treatment and clinical outcomes for high grade glioma","volume":"10","author":"Chien","year":"2015","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.jocn.2026.112101_b0090","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/1754-9485.13607","article-title":"Management and outcomes of glioblastoma: 20\u2010year experience in a single Australian institution","volume":"68","author":"Lenffer","year":"2023","journal-title":"J Med Imaging Radiat Oncol"},{"issue":"8","key":"10.1016\/j.jocn.2026.112101_b0095","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1007\/s10147-021-01929-5","article-title":"Current trend in treatment of glioblastoma in Japan: a national survey using the diagnostic procedure combination database (J-ASPECT study-glioblastoma)","volume":"26","author":"Funakoshi","year":"2021","journal-title":"Int J Clin Oncol"},{"issue":"6","key":"10.1016\/j.jocn.2026.112101_b0100","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.jocn.2010.10.016","article-title":"A retrospective survey of patients with malignant gliomas treated in the neuro-oncological care system under the Universal National Health Insurance program in Taiwan","volume":"18","author":"Huang","year":"2011","journal-title":"J Clin Neurosci"},{"issue":"16","key":"10.1016\/j.jocn.2026.112101_b0105","doi-asserted-by":"crossref","first-page":"6973","DOI":"10.7314\/APJCP.2014.15.16.6973","article-title":"One-year Survival Rate of patients with Primary Malignant Central nervous System Tumors after Surgery in Kazakhstan","volume":"15","author":"Akshulakov","year":"2014","journal-title":"Asian Pac J Cancer Prev"},{"key":"10.1016\/j.jocn.2026.112101_b0110","doi-asserted-by":"crossref","unstructured":"Bajwa, N. M. H., Khalid, N. M. U., Shah, N. M. M., Shamim, N. M. S., Laghari, N. a. A., Akhunzada, N. N. Z., Anis, N. S. B., Raghib, N. M. F., Siddiqi, N. S., & Enam, N. S. A. (2022). Treatment patterns of glioma in Pakistan: An epidemiological perspective. Journal of the Pakistan Medical Association, 72(11), S34\u2013S39. https:\/\/doi.org\/10.47391\/jpma.11-s4-akub05.","DOI":"10.47391\/JPMA.11-S4-AKUB05"},{"issue":"6","key":"10.1016\/j.jocn.2026.112101_b0115","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.7314\/APJCP.2014.15.6.2793","article-title":"Efficacy of high dose radiotherapy in post-operative treatment of glioblastoma multiform - a single institution report","volume":"15","author":"Pashaki","year":"2014","journal-title":"Asian Pac J Cancer Prev"},{"issue":"9","key":"10.1016\/j.jocn.2026.112101_b0120","first-page":"2613","article-title":"Survival analysis of glioblastoma multiforme","volume":"19","author":"Witthayanuwat","year":"2018","journal-title":"PubMed"},{"issue":"4","key":"10.1016\/j.jocn.2026.112101_b0125","doi-asserted-by":"crossref","first-page":"42","DOI":"10.21037\/cco.2020.02.05","article-title":"Management of glioblastoma: an Australian perspective","volume":"10","author":"Sim","year":"2020","journal-title":"Chin Clin Oncol"},{"key":"10.1016\/j.jocn.2026.112101_b0130","doi-asserted-by":"crossref","unstructured":"Galanis E, Buckner JC, Novotny P, Morton RF, McGinnis WL, Dinapoli R, Schomberg P, O'Fallon JR. Efficacy of neuroradiological imaging, neurological examination, and symptom status in follow-up assessment of patients with high-grade gliomas. J Neurosurg. 2000 Aug;93(2):201-7. doi: 10.3171\/jns.2000.93.2.0201. PMID: 10930004.","DOI":"10.3171\/jns.2000.93.2.0201"},{"issue":"2","key":"10.1016\/j.jocn.2026.112101_b0135","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/COC.0000000000000417","article-title":"Patterns of care and outcomes of hypofractionated chemoradiation versus conventionally fractionated chemoradiation for glioblastoma in the elderly population","volume":"41","author":"Haque","year":"2017","journal-title":"Am J Clin Oncol"},{"issue":"6","key":"10.1016\/j.jocn.2026.112101_b0140","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1002\/cam4.1070","article-title":"Hypofractionated short\u2010course radiotherapy in elderly patients with glioblastoma multiforme: an analysis of the National Cancer Database","volume":"6","author":"Mak","year":"2017","journal-title":"Cancer Med"},{"issue":"1","key":"10.1016\/j.jocn.2026.112101_b0145","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s13014-020-01584-6","article-title":"Survival after hypofractionation in glioblastoma: a systematic review and meta-analysis","volume":"15","author":"Trone","year":"2020","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.jocn.2026.112101_b0150","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.radonc.2021.01.003","article-title":"Hypofractionated radiotherapy in the real-world setting: an international ESTRO-GIRO survey","volume":"157","author":"Rodin","year":"2021","journal-title":"Radiother Oncol"},{"issue":"6","key":"10.1016\/j.jocn.2026.112101_b0155","article-title":"Challenges and opportunities with the use of hypofractionated radiation therapy in cancer care: Regional perspectives from South Korea, Japan, Singapore, and Australia","volume":"8","author":"Akimoto","year":"2023","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.jocn.2026.112101_b0160","unstructured":"International Atomic Energy Agency (2025). Number of Radiotherapy Machines Per Million Population. Retrieved from https:\/\/dirac.iaea.org\/Query\/Map."},{"key":"10.1016\/j.jocn.2026.112101_b0165","unstructured":"World Health Organization (2023). Medical devices: radiotherapy units (per million population), total density. Retrieved from https:\/\/www.who.int\/data\/gho\/data\/indicators\/indicator-details\/GHO\/total-density-per-million-population-radiotherapy-units."},{"key":"10.1016\/j.jocn.2026.112101_b0170","doi-asserted-by":"crossref","first-page":"942","DOI":"10.3332\/ecancer.2019.942","article-title":"Radiotherapy treatment in cancer control and its important role in Africa","volume":"13","author":"Ndlovu","year":"2019","journal-title":"Ecancermedicalscience"},{"key":"10.1016\/j.jocn.2026.112101_b0175","unstructured":"Insights10. (n.d.). India Radiotherapy Market Report 2022 to 2030. https:\/\/www.insights10.com\/report\/india-radiotherapy-market-analysis\/."},{"issue":"3","key":"10.1016\/j.jocn.2026.112101_b0180","doi-asserted-by":"crossref","first-page":"e30","DOI":"10.2349\/biij.4.3.e30","article-title":"Cancer care in Australia","volume":"4","author":"Koh","year":"2008","journal-title":"Biomed Imaging Intervention J"},{"issue":"9","key":"10.1016\/j.jocn.2026.112101_b0185","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1016\/j.jocn.2010.01.033","article-title":"Incidence and management of high grade glioma in M\u0101ori and non-M\u0101ori patients","volume":"17","author":"Alexander","year":"2010","journal-title":"J Clin Neurosci"},{"key":"10.1016\/j.jocn.2026.112101_b0215","unstructured":"Enam, S. A., Aziz, H. F., Bakhshi, S. K., Altaf, A., Siddiqui, K., Hafiz, A., Zaki, A., Osama, M., & Gilani, A. (2024). Consensus guidelines for the management of adult high-grade gliomas for low and middle-income countries. PubMed, 74(3 (Supple-3)), S100\u2013S108. https:\/\/doi.org\/10.47391\/jpma.s3.gno-12."},{"issue":"2","key":"10.1016\/j.jocn.2026.112101_b0220","doi-asserted-by":"crossref","first-page":"102","DOI":"10.4103\/2278-330X.110510","article-title":"Cancer care scenario in Bangladesh","volume":"2","author":"Uddin","year":"2013","journal-title":"South Asian Journal of Cancer"},{"issue":"1","key":"10.1016\/j.jocn.2026.112101_b0225","doi-asserted-by":"crossref","first-page":"12574","DOI":"10.1038\/s41598-025-95693-5","article-title":"Management and survival trends for diffuse gliomas diagnosed at a single neurooncology center in China during 2000 to 2020","volume":"15","author":"Li","year":"2025","journal-title":"Sci Rep"},{"key":"10.1016\/j.jocn.2026.112101_b0200","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.canlet.2020.10.050","article-title":"Clinical practice guidelines for the management of adult diffuse gliomas","volume":"499","author":"Jiang","year":"2020","journal-title":"Cancer Lett"},{"issue":"2","key":"10.1016\/j.jocn.2026.112101_b0230","doi-asserted-by":"crossref","first-page":"96","DOI":"10.4103\/glioma.glioma_14_19","article-title":"Real-world management and survival outcomes of patients with newly diagnosed gliomas from a single institution in China: a retrospective cohort study","volume":"2","author":"Chen","year":"2019","journal-title":"Glioma"},{"issue":"4","key":"10.1016\/j.jocn.2026.112101_b0235","doi-asserted-by":"crossref","first-page":"29","DOI":"10.21037\/cco-22-18","article-title":"A narrative review on the management of glioblastoma in China","volume":"11","author":"Zhao","year":"2022","journal-title":"Chin Clin Oncol"},{"issue":"33","key":"10.1016\/j.jocn.2026.112101_b0240","doi-asserted-by":"crossref","first-page":"4571","DOI":"10.2217\/fon-2021-0435","article-title":"Guideline Conformity to the Stupp Regimen in patients with newly Diagnosed Glioblastoma Multiforme in China","volume":"17","author":"Wang","year":"2021","journal-title":"Future Oncol"},{"issue":"2","key":"10.1016\/j.jocn.2026.112101_b0245","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s11060-013-1103-9","article-title":"Management and survival rates in patients with glioma in China (2004\u20132010): a retrospective study from a single-institution","volume":"113","author":"Yang","year":"2013","journal-title":"J Neurooncol"},{"issue":"7","key":"10.1016\/j.jocn.2026.112101_b0250","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.4103\/jcrt.JCRT_51_18","article-title":"Treatment of high-grade gliomas using escalating doses of hypofractionated simultaneous integrated boost-intensity-modulated radiation therapy in combination with temozolomide: a modified phase I clinical trial","volume":"14","author":"Ge","year":"2018","journal-title":"J Cancer Res Ther"},{"issue":"2","key":"10.1016\/j.jocn.2026.112101_b0255","first-page":"134","article-title":"Ten-year review of survival and management of malignant glioma in Hong Kong","volume":"23","author":"Chan","year":"2016","journal-title":"Hong Kong Med J"},{"issue":"1","key":"10.1016\/j.jocn.2026.112101_b0260","doi-asserted-by":"crossref","first-page":"81","DOI":"10.31557\/apjcc.2024.9.1.81-86","article-title":"The outcome of anaplastic glioma treated at a tertiary cancer care institute in South Asia","volume":"9","author":"Natarajan","year":"2024","journal-title":"Asian Pacific Journal of Cancer Care"},{"issue":"03","key":"10.1016\/j.jocn.2026.112101_b0265","doi-asserted-by":"crossref","first-page":"147","DOI":"10.4103\/2278-330X.187589","article-title":"Indian data on central nervous tumors: a summary of published work","volume":"05","author":"Dasgupta","year":"2016","journal-title":"South Asian Journal of Cancer"},{"key":"10.1016\/j.jocn.2026.112101_b0270","first-page":"259","article-title":"The first cross sectional survey on intracranial malignancy in Kolkata, India: reflection of the state of the art in Southern West Bengal","volume":"5","author":"Ghosh","year":"2004","journal-title":"Asian Pac J Cancer Prev"},{"key":"10.1016\/j.jocn.2026.112101_b0275","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctarc.2021.100302","article-title":"Return to work in survivors of Primary Brain Tumours treated with Intensity Modulated Radiotherapy","volume":"26","author":"Basalathullah","year":"2021","journal-title":"Cancer Treatment and Research Communications"},{"key":"10.1016\/j.jocn.2026.112101_b0280","doi-asserted-by":"crossref","unstructured":"Thakur, S., Kumar, N., Salunke, P., Ahuja, C., & Madan, R. (2022). A Randomized Study of Short Course (One Week) Radiation Therapy with or without Temozolomide in Elderly and\/or Frail Patients with Newly Diagnosed Glioblastoma (GBM). Asian Pacific Journal of Cancer Prevention, 23(7), 2317\u20132323. https:\/\/doi.org\/10.31557\/apjcp.2022.23.7.2317.","DOI":"10.31557\/APJCP.2022.23.7.2317"},{"issue":"2","key":"10.1016\/j.jocn.2026.112101_b0285","doi-asserted-by":"crossref","first-page":"127","DOI":"10.4103\/0019-509X.49150","article-title":"Therapy for glioma: Indian perspective","volume":"46","author":"Jalali","year":"2009","journal-title":"Indian J Cancer"},{"issue":"4","key":"10.1016\/j.jocn.2026.112101_b0290","doi-asserted-by":"crossref","first-page":"554","DOI":"10.4103\/crst.crst_295_23","article-title":"Bridging the cancer care gap and inequities in radiation treatment in India: a narrative review","volume":"6","author":"Gupta","year":"2023","journal-title":"Cancer Research Statistics and Treatment"},{"key":"10.1016\/j.jocn.2026.112101_b0300","doi-asserted-by":"crossref","unstructured":"Tanaka M, Ino Y, Nakagawa K, Tago M, Todo T. High-dose conformal radiotherapy for supratentorial malignant glioma: a historical comparison. Lancet Oncol. 2005 Dec;6(12):953-60. doi: 10.1016\/S1470-2045(05)70395-8. PMID: 16321763.","DOI":"10.1016\/S1470-2045(05)70395-8"},{"issue":"02","key":"10.1016\/j.jocn.2026.112101_b0305","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1055\/s-0042-1750779","article-title":"Comparison of glioblastoma outcomes in two geographically and ethnically distinct patient populations in disparate health care systems","volume":"17","author":"Mirza","year":"2022","journal-title":"Asian Journal of Neurosurgery"},{"issue":"8","key":"10.1016\/j.jocn.2026.112101_b0310","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1093\/jjco\/hyac060","article-title":"Current trend of radiotherapy for glioblastoma in the elderly: a survey study by the brain tumor Committee of the Korean Radiation Oncology Group (KROG 21\u201305)","volume":"52","author":"Wee","year":"2022","journal-title":"Jpn J Clin Oncol"},{"issue":"3","key":"10.1016\/j.jocn.2026.112101_b0315","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s11060-014-1660-6","article-title":"Pattern of care of anaplastic oligodendroglioma and oligoastrocytoma in a Korean population: the Korean radiation oncology group study 13-12","volume":"121","author":"Yu","year":"2014","journal-title":"J Neurooncol"},{"issue":"28","key":"10.1016\/j.jocn.2026.112101_b0320","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000033955","article-title":"Reduced volume intensity-modulated radiotherapy with simultaneous integrated boost for patients with high-grade glioma: a retrospective observational study","volume":"102","author":"Kang","year":"2023","journal-title":"Medicine"},{"issue":"2","key":"10.1016\/j.jocn.2026.112101_b0325","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s11060-024-04853-6","article-title":"Comparative analysis of hypofractionated short-course versus standard radiation therapy in elderly patients with glioblastoma: analysis of nationwide database","volume":"171","author":"Won","year":"2024","journal-title":"J Neurooncol"},{"key":"10.1016\/j.jocn.2026.112101_b0330","unstructured":"Chansriwong, P., & Sirisinha, T. (2010). Clinical features, management and outcomes of high-grade glioma patients in Ramathibodi Hospital. PubMed, 93 Suppl 2, S68-73. https:\/\/pubmed.ncbi.nlm.nih.gov\/21299082."},{"key":"10.1016\/j.jocn.2026.112101_b0335","doi-asserted-by":"crossref","DOI":"10.1016\/j.bas.2023.101775","article-title":"Glioblastoma management in low and middle-income countries; existing challenges and policy recommendations","volume":"3","author":"Tebha","year":"2023","journal-title":"Brain and Spine"}],"container-title":["Journal of Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586826002523?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586826002523?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T23:36:16Z","timestamp":1790638576000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0967586826002523"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":66,"alternative-id":["S0967586826002523"],"URL":"https:\/\/doi.org\/10.1016\/j.jocn.2026.112101","relation":{},"ISSN":["0967-5868"],"issn-type":[{"value":"0967-5868","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Radiotherapy for newly diagnosed adult high grade gliomas in the Asia Pacific Region","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jocn.2026.112101","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"112101"}}